These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Establishment of a porcine model of acute hepatic failure by intraportal injection of D-galactosamine and lipopolysaccharide]. Peng CH; Xiao WD; Wu WD; Zhou GW; Zhang MJ; Shu M; Chen HX; Li HW Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1464-7. PubMed ID: 16061023 [TBL] [Abstract][Full Text] [Related]
4. Auxiliary partial orthotopic liver transplantation for fulminant hepatitis: regeneration of the diseased native liver in a pig model. Ishiguro S; Takada Y; Gu M; Fukunaga K; Taniguchi H; Seino K; Kawamoto T; Yuzawa K; Otsuka M; Todoroki T; Fukao K Transplantation; 2003 Jun; 75(11):1901-4. PubMed ID: 12811253 [TBL] [Abstract][Full Text] [Related]
8. An improved model of galactosamine-induced fulminant hepatic failure in the pig. Kalpana K; Ong HS; Soo KC; Tan SY; Prema Raj J J Surg Res; 1999 Apr; 82(2):121-30. PubMed ID: 10090819 [TBL] [Abstract][Full Text] [Related]
10. Up-regulation of hepatocyte growth factor caused by an over-expression of transforming growth factor beta, in the rat model of fulminant hepatic failure. Nozato E; Shiraishi M; Nishimaki T J Surg Res; 2003 Dec; 115(2):226-34. PubMed ID: 14697288 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of double-filtration plasmapheretic cross-circulation with a high-permeability membrane using canine harvested liver in porcine fulminant hepatic failure model. Ishizawa Y; Totsuka E; Umehara M; Nishimura A; Ono H; Sasaki M Transplant Proc; 2004 Oct; 36(8):2344-8. PubMed ID: 15561244 [TBL] [Abstract][Full Text] [Related]
12. Effects of large-pore hemofiltration in a swine model of fulminant hepatic failure. Detry O; Janssen N; Cheramy-Bien JP; Cavalier E; Defraigne JO; Delanaye P; Lambermont B Artif Organs; 2012 Nov; 36(11):981-7. PubMed ID: 22888863 [TBL] [Abstract][Full Text] [Related]
13. A bioartificial liver that combines plasma dialysis and whole liver perfusion. Umehara M; Totsuka E; Ishizawa Y; Nara M; Hakamada K; Umehara Y; Sasaki M Hepatogastroenterology; 2008; 55(85):1216-21. PubMed ID: 18795660 [TBL] [Abstract][Full Text] [Related]
18. In vivo efficacy of a bioartificial liver in improving spontaneous recovery from fulminant hepatic failure: a controlled study in pigs. Cuervas-Mons V; Colás A; Rivera JA; Prados E Transplantation; 2000 Feb; 69(3):337-44. PubMed ID: 10706039 [TBL] [Abstract][Full Text] [Related]
19. Transplantation of hepatocytes for prevention of intracranial hypertension in pigs with ischemic liver failure. Arkadopoulos N; Chen SC; Khalili TM; Detry O; Hewitt WR; Lilja H; Kamachi H; Petrovic L; Mullon CJ; Demetriou AA; Rozga J Cell Transplant; 1998; 7(4):357-63. PubMed ID: 9710304 [TBL] [Abstract][Full Text] [Related]
20. An inhibitor of c-Jun NH2-terminal kinase, SP600125, protects mice from D-galactosamine/lipopolysaccharide-induced hepatic failure by modulating BH3-only proteins. Takamura M; Matsuda Y; Yamagiwa S; Tamura Y; Honda Y; Suzuki K; Ichida T; Aoyagi Y Life Sci; 2007 Mar; 80(14):1335-44. PubMed ID: 17300814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]